Remove Cannabinoids Remove Data Remove Epilepsy Remove Sativa
article thumbnail

Analysts Envision a $33.2 Billion Medical Cannabis Market By 2027

Veriheal

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Alzheimer’s.

article thumbnail

Marijuana & COVID-19: Top Studies [August 2020]

CannaMD

Marijuana cannabinoid, CBD. While future research is needed, the present study opens up a new landscape for marijuana research – focusing on terpenes just as much as cannabinoids. Our initial data suggest that some C. sativa is a novel and crucial finding. .” And their alternative strategy of choice?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94
article thumbnail

Study Suggests That THC is More Efficient at Providing Symptomatic Relief for Nausea Than CBD

Veriheal

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 billion in legal U.S.

THC 52
article thumbnail

FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products

Cannabis Law Report

Like CBD, delta-8 THC is also derived from the Cannabis sativa plant. In the Warning Letters, FDA expresses concern with the use of chemicals to convert other cannabinoids in the plant into delta-8 THC. The agency cites a lack of data on the potential residues of these substances that would reach the human consumer.

THC 52
article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Cannabis sativa with more than 0.3% Consumers spent roughly $31.3

CBD 144
article thumbnail

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. But do medical cannabinoids actually help animal patients? She sought to make sense of the issues during her presentation “Medical Cannabinoids Revisited” at AVMA Virtual Convention 2021 on Aug.

Patients 105